lidocaine has been researched along with Hepatitis in 11 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Hepatitis: INFLAMMATION of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Liver cirrhosis was produced in rats by intra-abdominal injection of thioacetamide." | 7.71 | Reassessment of monoethylglycinexylidide as preoperative liver function test in a rat model of liver cirrhosis and man. ( Ishii, T; Kaneko, H; Katagiri, M; Maeda, T; Otsuka, Y; Shiba, T; Takagi, S; Tamura, A; Tsuchiya, M, 2001) |
| "Liver cirrhosis was produced in rats by intra-abdominal injection of thioacetamide." | 3.71 | Reassessment of monoethylglycinexylidide as preoperative liver function test in a rat model of liver cirrhosis and man. ( Ishii, T; Kaneko, H; Katagiri, M; Maeda, T; Otsuka, Y; Shiba, T; Takagi, S; Tamura, A; Tsuchiya, M, 2001) |
| "Patients with acute hepatitis and patients with compensated or decompensated cirrhosis of the liver have a decreased plasma clearance of hexobarbital." | 3.66 | [Drug metabolism in patients with liver disease (author's transl)]. ( Epping, J; Fuchshofen-Röckel, M; Heusler, H; Richter, E; Zilly, W, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchshofen, M | 1 |
| Heusler, H | 2 |
| Lutz, B | 1 |
| Mora, E | 1 |
| Richter, E | 2 |
| Epping, J | 1 |
| Fuchshofen-Röckel, M | 1 |
| Zilly, W | 1 |
| Ziebell, J | 1 |
| Shaw-Stiffel, TA | 1 |
| Shiffman, ML | 2 |
| Luketic, VA | 2 |
| Sanyal, AJ | 2 |
| Duckworth, PF | 1 |
| Purdum, PP | 2 |
| Contos, MJ | 1 |
| Mills, AS | 1 |
| Edinboro, LE | 1 |
| Poklis, A | 1 |
| Huang, YS | 1 |
| Lee, SD | 1 |
| Deng, JF | 1 |
| Wu, JC | 1 |
| Lu, RH | 1 |
| Lin, YF | 1 |
| Wang, YJ | 1 |
| Lo, KJ | 1 |
| Fisher, RA | 1 |
| Posner, MP | 1 |
| Giannini, E | 1 |
| Botta, F | 1 |
| Romagnoli, P | 1 |
| Testa, R | 1 |
| Ol'rikh, M | 1 |
| Kukes, VG | 1 |
| Igonin, AA | 1 |
| Kaneko, H | 1 |
| Otsuka, Y | 1 |
| Katagiri, M | 1 |
| Maeda, T | 1 |
| Tsuchiya, M | 1 |
| Tamura, A | 1 |
| Ishii, T | 1 |
| Takagi, S | 1 |
| Shiba, T | 1 |
| Villeneuve, JP | 1 |
| Thibeault, MJ | 1 |
| Ampelas, M | 1 |
| Fortunet-Fouin, H | 1 |
| LaMarre, L | 1 |
| Côté, J | 1 |
| Pomier-Layrargues, G | 1 |
| Huet, PM | 1 |
| Adjepon-Yamoah, KK | 1 |
| Nimmo, J | 1 |
| Prescott, LF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis[NCT00244569] | Phase 3 | 120 participants (Anticipated) | Interventional | 2005-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for lidocaine and Hepatitis
| Article | Year |
|---|---|
Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
Topics: Adult; Chronic Disease; Female; Follow-Up Studies; Galactose; Hepatitis; Humans; Indocyanine Green; | 1993 |
10 other studies available for lidocaine and Hepatitis
| Article | Year |
|---|---|
[Lidocain clearance after oral and intravenous application in rats with low grade ANIT-cholestasis and galactosamine-induced hepatitis (author's transl)].
Topics: 1-Naphthylisothiocyanate; Administration, Oral; Animals; Biological Availability; Chemical and Drug | 1980 |
[Drug metabolism in patients with liver disease (author's transl)].
Topics: Acute Disease; Adult; Antipyrine; Biological Availability; Biotransformation; Cholestasis; Female; H | 1980 |
Quantitative liver testing with MEG-X: more optimism?
Topics: Autoimmune Diseases; Biopsy; Hepatitis; Hepatitis C; Lidocaine; Liver; Reproducibility of Results | 1995 |
Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis.
Topics: Adult; Aged; Alanine Transaminase; Chronic Disease; Female; Hepatitis; Humans; Lidocaine; Liver; Liv | 1994 |
Hepatic lidocaine metabolism is useful in the selection of patients in need of liver transplantation.
Topics: Hepatitis; Humans; Lidocaine; Liver; Liver Cirrhosis; Liver Diseases; Liver Transplantation | 1993 |
Oral or intravenous lidocaine administration to perform megx test?
Topics: Administration, Oral; Diagnosis, Differential; Hepatitis; Humans; Infusions, Intravenous; Lidocaine; | 2000 |
[Role of lidocaine metabolism studies in the diagnosis of liver diseases].
Topics: Adult; Animals; Clinical Enzyme Tests; Critical Care; Diagnosis, Differential; Dogs; Female; Hepatit | 2000 |
Reassessment of monoethylglycinexylidide as preoperative liver function test in a rat model of liver cirrhosis and man.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Disease Models, Animal; Hepat | 2001 |
Drug disposition in patients with HBsAg-positive chronic liver disease.
Topics: Adult; Aminopyrine; Antipyrine; Female; Hepatitis; Hepatitis B Surface Antigens; Hepatitis, Chronic; | 1987 |
Gross impairment of hepatic drug metabolism in a patient with chronic liver disease.
Topics: Adult; Antipyrine; Biotransformation; Chronic Disease; Female; Half-Life; Hepatitis; Humans; Jaundic | 1974 |